Tema Oncology ETF (CANC)
NASDAQ: CANC
· Real-Time Price · USD
27.69
0.76 (2.80%)
At close: Sep 11, 2025, 2:55 PM
CANC Holdings List
As of Sep 10, 2025
The Tema Oncology ETF is an equity ETF with a total of 47 individual holdings.
The top holdings are Revolution Medicines at 6.00%, Eli Lilly and Company at 4.96%, BridgeBio Pharma at 4.79%, Genmab A/S at 4.57%, and Roche at 4.26%.
47
41.16%
Equity
75.63M
26.07
0.7500%
Sector Allocation
| Rank | Symbol | Name | Price | % Change | Shares | % Weight |
|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medi... | 45.41 | +12.25% | 109.31K | 6.00% |
| 2 | LLY | Eli Lilly and C... | 758.75 | +0.55% | 4.93K | 4.96% |
| 3 | BBIO | BridgeBio Pharm... | 52.86 | -0.19% | 66.72K | 4.79% |
| 4 | GMAB | Genmab A/S | 28.52 | +2.85% | 122.58K | 4.57% |
| 5 | RHHBY | Roche Holding A... | 42.06 | +0.50% | 74.74K | 4.26% |
| 6 | MRUS | Merus N.V. | 69.55 | +3.60% | 42.9K | 3.94% |
| 7 | ONC | BeOne Medicines... | 335.36 | +6.83% | 7.26K | 3.42% |
| 8 | NUVL | Nuvalent, Inc. | 82.72 | +5.38% | 29.91K | 3.16% |
| 9 | ACLX | Arcellx, Inc. | 76.20 | +4.80% | 31.9K | 3.08% |
| 10 | EXEL | Exelixis, Inc. | 38.62 | +2.44% | 57.99K | 2.98% |
| 11 | BMY | Bristol-Myers S... | 47.61 | +0.98% | 46.84K | 2.96% |
| 12 | ABBV | AbbVie Inc. | 221.01 | +4.43% | 9.98K | 2.82% |
| 13 | ZLAB | Zai Lab Limited | 32.13 | +13.13% | 60.73K | 2.56% |
| 14 | LEGN | Legend Biotech ... | 33.82 | +1.05% | 53.37K | 2.45% |
| 15 | IDYA | IDEAYA Bioscien... | 24.93 | +0.89% | 65.61K | 2.18% |
| 16 | MRK | Merck & Co., In... | 85.17 | +1.36% | 19.06K | 2.16% |
| 17 | AMGN | Amgen Inc. | 282.44 | +1.41% | 5.67K | 2.13% |
| 18 | ARGX | argenx SE | 760.95 | -0.25% | 1.99K | 2.04% |
| 19 | SMMT | Summit Therapeu... | 18.61 | +5.71% | 78.56K | 1.98% |
| 20 | GILD | Gilead Sciences... | 117.24 | +1.73% | 12.39K | 1.92% |
| 21 | CELC | Celcuity Inc. | 56.18 | +0.45% | 21.55K | 1.76% |
| 22 | SNDX | Syndax Pharmace... | 16.30 | +3.62% | 81.25K | 1.74% |
| 23 | IMNM | Immunome, Inc. | 9.51 | +5.67% | 134.22K | 1.66% |
| 24 | COGT | Cogent Bioscien... | 12.72 | -0.24% | 87.99K | 1.51% |
| 25 | CGON | CG Oncology, In... | 33.44 | -0.56% | 29.58K | 1.33% |
| 26 | REGN | Regeneron Pharm... | 568.75 | +2.32% | 1.77K | 1.32% |
| 27 | ZYME | Zymeworks Inc. | 16.24 | +6.93% | 62.3K | 1.27% |
| 28 | JANX | Janux Therapeut... | 24.56 | +1.03% | 39.49K | 1.26% |
| 29 | URGN | UroGen Pharma L... | 19.31 | +1.05% | 38.58K | 1.07% |
| 30 | ELVN | Enliven Therape... | 19.50 | +1.43% | 39.45K | 1.04% |
| 31 | IMCR | Immunocore Hold... | 36.27 | -0.36% | 20.91K | 1.03% |
| 32 | NRIX | Nurix Therapeut... | 9.14 | +2.12% | 76.37K | 0.94% |
| 33 | HCM | HUTCHMED (China... | 16.34 | +4.04% | 40.08K | 0.86% |
| 34 | NUVB | Nuvation Bio In... | 3.35 | +1.05% | 191.12K | 0.86% |
| 35 | RCUS | Arcus Bioscienc... | 11.60 | -1.02% | 56.18K | 0.85% |
| 36 | GH | Guardant Health... | 57.12 | +0.96% | 10.07K | 0.80% |
| 37 | AAPG | Ascentage Pharm... | 39.70 | +2.45% | 10.38K | 0.56% |
| 38 | IOVA | Iovance Biother... | 2.40 | +0.84% | 170.13K | 0.54% |
| 39 | RLAY | Relay Therapeut... | 4.04 | -0.37% | 91.45K | 0.50% |
| 40 | DAWN | Day One Biophar... | 7.30 | +0.62% | 44.7K | 0.44% |
| 41 | SDGR | Schrödinger, In... | 18.68 | +2.92% | 16.47K | 0.43% |
| 42 | ARVN | Arvinas, Inc. | 7.79 | -0.57% | 37.99K | 0.41% |
| 43 | ILMN | Illumina, Inc. | 99.20 | +3.89% | 3.08K | 0.41% |
| 44 | CGEM | Cullinan Therap... | 6.45 | -0.28% | 40.19K | 0.37% |
| 45 | REPL | Replimune Group... | 6.06 | +1.17% | 42.04K | 0.33% |
| 46 | ANAB | AnaptysBio, Inc... | 23.45 | +2.92% | 10.74K | 0.32% |
| 47 | AUTL | Autolus Therape... | 1.46 | +5.43% | 113.33K | 0.21% |